Healthcare >> Analyst Interviews >> April 19, 2010
Dr. Sean Lavin, M.D., is a Senior Analyst who covers the medical technology space. He joined Lazard Capital Markets in March 2008. Prior to joining Lazard Capital Markets, Dr. Lavin was a sell-side Analyst at Oppenheimer & Co., where he covered medical devices and diagnostics. He focuses on minimally invasive devices and those which he believes can change the standard of care. Prior to joining Oppenheimer, Dr. Lavin worked as a Surgical Resident at Mount Sinai Medical Center, in Miami Beach, Fla. While there, he participated in general, plastic, trauma, vascular, cardiothoracic and urologic surgery cases, and he cared for patients in the ICU, emergency room and burn unit. Dr. Lavin has an M.D. from the Ohio State University College of Medicine and a B.S. in chemistry with a minor in biology and a concentration in economics from the Massachusetts Institute of Technology. Profile
TWST: How have the prospects for the medical devices industry changed, if at all, since the last time we spoke?
Dr. Lavin: I don't think it has changed much. I mean, we spoke recently enough that the
